palmidrol has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roncati, L | 1 |
| Lusenti, B | 1 |
| Pellati, F | 1 |
| Corsi, L | 1 |
1 review available for palmidrol and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation.
Topics: Amides; Anti-Inflammatory Agents; Antiphospholipid Syndrome; COVID-19; COVID-19 Drug Treatment; Etha | 2021 |